Skip to main content

Table 5 Echocardiographic variables according to the carrier status of the mutant A allele at NDUFC2/rs641836.

From: Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension

Variables

GG

n = 152

GA + AA

n = 94

NDUFC2

rs641836

p-value; (R2)

Total model

p-value;

(R2)

Septal thickness (mm)

9.7 ± 1.6

10.6 ± 1.6

0.001;

(17.8%)

0.017;

(11.0%)

LVPW (mm)

9.2 ± 1.5

10.4 ± 1.4

0.001;

(26.8%)

0.011;

(20.8%)

RWT

0.40 ± 0.06

0.43 ± 0.06

0.005;

(9.8%)

0.257;

(2.3%)

LV mass (g)

158.1 ± 42.9

191.1 ± 49.7

0.001;

(32.3%)

0.003;

(26.7%)

LV mass/BSA (g/m2)

85.0 ± 21.4

104.0 ± 25.2

0.001;

(26.8%)

0.002;

(20.7%)

LV mass/h2.7 (g/m2.7)

36.7 ± 11.9

43.5 ± 13.8

0.002;

(18.7%)

0.010;

(12.2%)

LA vol/h2 (ml/m2)

14.8 ± 3.4

15.6 ± 2.8

0.062

(6.8%)

0.071

(4.7)

  1. Each row represents a covaried 1-way analysis of variance of 1 individual cardiac parameter, considered as the dependent variable. The column titled NDUFC2 rs641836 reports the significance (p-value) and amount of variability (R2) explained by the effect of the carrier status of the mutant A allele of NDUFC2 rs641836 independently of all covariates (age, gender, BMI, BP, combination therapy, number of antihypertensive drugs). The column titled Total Model reports the significance (p-value) and amount of variability (R2) explained by the complete analysis